Form 4 for PRTA PROTHENA CORP PUBLIC LTD CO
Accepted 2021-10-01 00:00:00 ET · period of report 2021-10-01 · accession 0001140361-21-033351 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-01 | 2021-10-01 | PRTA | Selkoe Dennis J. | Dir | S - Sale+OE | $67.83 | -5,000 | 3,551 | -58% | -$339.2K |
| D | 2021-10-01 | 2021-10-01 | PRTA | Selkoe Dennis J. | Dir | M - OptEx | $9.23 | +5,000 | 7,845 | +176% | +$46.1K |
| D | 2021-10-01 | 2021-10-01 | PRTA | Selkoe Dennis J. | Dir | M - OptEx | $0.00 | -5,000 | 11.0K | -31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares, par value $0.01 per share | 2021-10-01 | S | D | 706 | $69.69 | 2,845 | D | — | — | (F5) The transaction was executed in multiple trades in prices ranging from $69.49 to $70.44, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 2 | Common | Ordinary Shares, par value $0.01 per share | 2021-10-01 | S | D | 1,300 | $67.96 | 4,788 | D | — | — | (F3) The transaction was executed in multiple trades in prices ranging from $67.33 to $68.26, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Ordinary Shares, par value $0.01 per share | 2021-10-01 | S | D | 1,757 | $66.35 | 6,088 | D | — | — | (F2) The transaction was executed in multiple trades in prices ranging from $66.14 to $67.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 4 | Common | Ordinary Shares, par value $0.01 per share | 2021-10-01 | M | A | 5,000 | $9.23 | 7,845 | D | — | — | |
| 5 | Common | Ordinary Shares, par value $0.01 per share | 2021-10-01 | S | D | 1,237 | $68.74 | 3,551 | D | — | — | (F4) The transaction was executed in multiple trades in prices ranging from $68.44 to $69.30, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-10-01 | M | D | 5,000 | $0.00 | 11,000 | D | $9.23 · 2020-05-18 to 2029-05-22 | 5,000 Ordinary Shares |